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The clinical course of 59 patients with coronary artery
spasm and no fixedsevere coronary obstruction was ana-
lyzed for an average of 5.9 years. The study group con-
sisted of 27 men and 32 women.
Angina at rest was the predominant symptom in 93%
of the patients. Myocardial infarction occurred in 19%
and syncope during angina in 27%. During spontaneous
anginal episodes, 64% ofthe patients showedST segment
elevation, 17% ST segment depression and 15% no
electrocardiographic changes. Major arrhythmias dur-
ing angina occurred in 24% of the patients. Permanent
pacemakers were required in 10% of the patients. Stress
tests were positive in 32% of the patients. Long-acting
nitrate therapy controlled symptoms in only 31%, and
During the past 10 years, increasing attention has been fo-
cused on a rare manifestation of ischemic heart disease: the
syndrome of coronary artery spasm without fixed, severe
coronary atherosclerotic obstruction. Numerous reports (1-
7) have detailed the clinical manifestations, diagnostic methods
and treatment of patients with this syndrome; however, little
information is available concerning its natural history. Be-
cause the syndrome of pure coronary artery spasm is rare,
most reports of its natural history contain only a small num-
ber of cases and include patients both with and without fixed
severe obstruction (l,3,8).
To clarify the natural history of medically treated patients
with pure coronary artery spasm, we analyzed the clinical
course of all patients identified with this syndrome at The
Cleveland Clinic during a 20 year period. We excluded those
with fixed severe coronary atherosclerotic obstruction be-
cause such obstruction may exert an independent influence
on the clinical course.
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calcium antagonist agents controlled symptoms in 83%
of the patients unresponsive to nitrates. Spontaneous
remission of angina for at least 1 month while receiving
no medical treatment occurred in 39% of the patients.
Fifteen percent of patients had an indefinite remission
with no recurrence of symptoms for at least 2 years.
There were no cardiac deaths.
The natural history of medically treated patients with
pure coronary spasm is characterized by recurrent an-
gina at rest, frequent spontaneous remission, a poor
response to long-acting nitrate therapy and a good re-
sponse to calcium antagonists. Although myocardial in-
farction and major arrhythmias are common, cardiac
mortality is low in medically treated patients.
Methods
Patients. Between December 1962 and November 1981,
59 patients with pure coronary artery spasm were identified
at The Cleveland Clinic. All had normal or mildly abnormal
coronary arteriograms « 50% narrowing of coronary lu-
minal diameter) and met one or more of the following cri-
teria for symptomatic coronary artery spasm: 1) Prinzmetal' s
variant angina, 2) positive ergonovine provocative test, or
3) spontaneous coronary artery spasm (> 75% coronary
luminal narrowing) visualized during coronary arteriog-
raphy and associated with transient ischemic electrocardio-
graphic changes or angina pectoris.
Prinzmetal's variant angina is defined as: I) recurrent
episodes of angina at rest, 2) transient ST segment elevation
during anginal attacks, and 3) normalization of the electro-
cardiogram between attacks with no evidence of myocardial
infarction (9), The ergonovine provocative test was per-
formed according to a protocol described previously (4).
The test was considered positive if it produced more than
75% narrowing of coronary luminal diameter on angiog-
raphy. When the test was performed outside the catheter-
ization laboratory, it was considered positive if angina and
transient ischemic electrocardiographic changes developed
within 10 minutes.
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gina in 47 of the 59 patients. Of the seven patients (15%)
who had no electrocardiographic change during spontaneous
attacks of angina. four had either ST elevation or depression
during induced attacks in the catheterization laboratory.
Graded maximal vectorcardiographic stress tests were per-
formed in 44 patients.
Catheterization findings (Table 3). An ergonovine
provocative test was performed in 44 of the 59 patients.
Severe coronary spasm, either spontaneous or induced by
ergonovine, was observed during coronary arteriography in
53 patients. No patient had a myocardial infarction or died
as a result of the ergonovine test.
Therapy. Long-acting nitrate therapy was initiated in
51 patients and resulted in control of angina in 16 patients
(31 %). In 23 patients whose anginal attacks were not con-
trolled by isosorbide dinitrate (mean dose 83 mg/day) cal-
cium antagonist therapy controlled symptoms in 83%. Twenty
patients were treated with nifedipine (mean dose 60 mgt
day) and three with verapamil (mean dose 480 mg/day).
Before calcium antagonist agents became available, six pa-
Table l. Clinical Manifestations in 59 PatientsClinical manifestations. A history of myocardial in-
farction was determined by prolonged anginal pain accom-
panied by new Q waves or typical evolutionary ST-T wave
changes, or both, associated with an increase in cardiac
enzymes. Major arrhythmias included asystole. high grade
heart block, ventricular tachycardia and ventricular fibril-
lation. Spontaneous remission was defined as an absence of
angina pectoris for I month or longer while the patient was
receiving no medical treatment. Remissionswereconsidered
short-term when they persisted for up to 6 months and long-
term when they persisted for more than 6 months. Patients
with both long- and short-term remissions were included in
the group with long-term remissions.
Therapy. Patients were initiaIlytreated with long-acting
nitrates. Therapy was considered to result in control of
symptoms if the frequency of angina pectoris decreased from
more than once a week before treatment to once a week or
less, or if it decreased by 50% in patients who had angina
less than once a week before treatment. If symptoms were
not controIled with long-acting nitrate therapy, patients were
started on calcium antagonist therapy when it became avail-
able in February 1976. AIl patients used sublingual nitro-
glycerin as needed for acute attacks of angina pectoris.
Aortocoronary bypass surgery was performed between 1973
and 1975 in selected patients whose symptoms could not be
controlled with available medical therapy.
Follow-up. Fifty-eight patients were contacted by tele-
phone and one patient by letter in January 1982. Inquiries
were made regarding current medications, frequency of chest
pain, syncope, myocardial infarction, arrhythmias. repeat
cardiac catheterization, coronary bypass surgery and any
attempts to withdraw medical therapy. AIl charts were
reviewed.
Results
Clinical manifestations (Table 1). The average age of
onset of symptoms was 48 years (range 36 to 75). The
clinical course of each patient was analyzed from the onset
of symptoms for an average of 5.9 years (range 6 months
to 20 years). The average follow-up period from time of
diagnosis was 4 years. Exertional angina never occurred as
an isolated symptom because all patients also had angina at
rest. Acute myocardial infarction occurred in II patients.
It was the initial symptom in three patients and was preceded
by a history of angina at rest in eight patients. Myocardial
infarction never occurred as an isolated clinical event, be-
cause all patients subsequently had angina at rest. ST seg-
ment elevation during angina at rest occurred in 10 of the
II patients with myocardial infarction and corresponded to
the location of the infarct. Two patients died of carcinoma
of the lung but no cardiac deaths occurred.
Electrocardiographic findings (Table 2). Electrocar-
diograms were obtained during spontaneous attacks of an-
TraIt
Sex
Male
Female
Predominant symptom
Angina at rest
Exertional angina
Syncope with angina
Spontaneous remission
Long-term
Short-term
Myocardial mfarcnon
Cardiac death
Table 2. Electrocardiographic (ECG) Findings
Trait
Rest ECG
Normal
Abnormal
ECG dunng spontaneous angina
ST elevation with all attacks
ST depression with all attacks
No ECG change
Major arrhythmias during angina
Asystole
High grade heart block
Ventricular tachyarrhythmias
Posrtive stress test
ST elevation
ST depression
Frequency (% )
46
54
93
7
27
39
24
15
19
o
Frequency (%)
75
25
64
17
15
24
3
12
19
32
9
23
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tients received aortocoronary bypass grafts because their
symptoms could not be controlled with long-acting nitrate
therapy. Two of these patients were pain-free during the
first 6 months after operation , but all six patients eventually
had a recurrence of angina at rest. Six patients (10%) re-
quired implantation of a permanent pacemaker because of
recurrent syncope due to bradyarrhythmias during chest pain.
Discussion
Patient selection. The patients in this study constituted
a well defined group of subjects with symptomatic coronary
artery spasm and no fixed severe coronary obstructions. It
is possible that the group contained a disproportionate num-
ber of patients with more disabling symptoms, because those
with mild symptoms may have gone unrecognized, and those
who responded to medical therapy for angina pectoris may
not have been referred to us. Patient s seen early in our series
were usually more symptomatic than those seen later. This
difference was probably due to an increased awareness of
coronary spasm in recent years and the use of specific di-
agnostic methods, such as electrocardiography during pain
and the ergonovine provocative test.
Clinical manifestations. Patient s with pure coronary
spasm are generally younger (average age 48 years) and
more frequently female (54%) compared with patient s with
typical exertional angina . Howe ver , these differences are
not sufficient to be clinicall y helpful in eva luating patients
with chest pain .
Patient s with pure coronary artery spasm can usually be
recognized by the characteristic history of recurrent angina
at rest , especially nocturnal angina (1,2, 10). In this study,
angina at rest was the predominant symptom in 93% of
patient s and exertional angina in 7%. Several authors (11-
13) have demonstrated that exerti on may precipitate symp-
tomatic coronary spasm in patients without fixed severe
obstruction. However, exertional angina occurs in only a
minority of patients with pure coronary spasm, and when
it does occur, it is usually a minor part of the clinical picture.
Table 3. Catheterization Findings
Trait
Posuive ergonovine test
Spontaneous coronary artery spasm
Coronary artery Involved in spasm
Right
Left anterior descending
Left circumflex
Left main
More than one artery
Abnormal left ventriculogram
Frequency (%)
98
32
55
38
28
4
19
19
In occasional patients, exertional angina is the predominant
clinical manifestation of pure coronary spasm, but in such
patients, rest pain is also nearly alway s present (14).
Syncope during angina is characteristic of patients with
pure coronary artery spasm and occurs in approx imately
one-fourth of patients (15- 17) . In our study, syncope oc-
curred in 27% of patient s and was usually precipitated by
an arrhythmia. Coronary spasm rarely produces syncope
without angina (18).
Remission of symptoms. Spontaneous remission of
symptoms has been recognized previously as part of this
syndrome (19 ). In our study , remissions occurred in 39%
of patients and often lasted for 6 month s or longer. This
pattern of fluctuating activity of the disea se is similar to that
seen with cluster headaches, and makes it very difficult to
evaluate medical therapy. It is interesting that 9 (15 % ) of
our 59 patients had spontan eous remission of symptoms for
at least 2 years and remained asymptomatic at last fol-
low-up . This may mean that the disease "bums itself out"
and does not recur in some patients. However,S of our 14
patients who had a long-term remis sion eventually had a
recurrence of symptoms. Th is sugges ts that long-term re-
mission does not necessarily mean that the tendency toward
coronary spasm has disappeared permanentl y. Girotti et al.
( 19) also observed such long-term remissions and they spec-
ulated that spontaneous and permanent complete remissions
may occur in some patients with Prinzmetal' s variant angina.
Waters et al . (20) demonstrated that the ergonovine pro -
vocative test becomes negative during spontaneous remis-
sions. Therefore, this test appears to be helpful not only in
the diagnosis of spasm, but also in assessing the activity of
the disease . This may be important in deciding if medical
therapy can be safely discontinued in asymptomatic patients.
We believe that because coronary spasm may recur even
after a remission of I year or more , therapy should not be
discontinued, especially in patient s with a history of myo-
cardial infarction, syncope or life-threatening arrhythmias
due to spasm.
The pathophysiology of coronary artery spasm and the
fa ctors that induce remission remain obscure. In our pa-
tients, neither the onset nor remission of coronary spasm
manifested an obvious relation to emotional stress, time of
year, concurrent diseases or alcohol consumption. However,
our study was not prospectively designed to analyze these
factors. Two drugs that were administered for treatm ent of
migraine headache (Cafergot, which contains ergotamine
tartrate , and Sansert, an ergot derivative) prec ipitated angina
in three of our patient s. Imipramine , a tricyclic antidepres-
sant, was implicated in precipitating coronary spasm in one
of our patient s. Other investigators (2 1,22) reported that
alcohol ingestion may induce attacks of variant angina.
Freedman et al. (23) reported that failure to stop smoking
was associated with a higher recurrence of angina when
medical treatment was withdrawn in patients with pure coro-
lACC Vol. 2. No 2
August 1983'200 -5
Borr-sILvERMAN AND HEUPLER
NATURAL HISTORY OF PURE CORONARY SPASM
203
nary spasm. In our study, no relation between cigarette
smoking and activity of disease was apparent.
Myocardial infarction. In this study. myocardial in-
farction occurred in II (19%) of 59 patients. Repeated at-
tacks of angina at rest occurred in eight of these patients
before infarction and in all patients after infarction. The
location of ST elevation during rest pain always corre-
spondedto the location of the infarct.This is strongevidence
that spasm may produce acute myocardial infarction in pa-
tients with normal or mildly abnormal coronary arteries. In
a previous study(4) of patientswithnormal coronaryarteries
who presented with myocardial infarction as an isolated
clinical event, the ergonovine test for coronary spasm was
consistently negative. It is possible that coronary spasm
plays a role in such patients but that the ergonovine test
was negative because the patients were in remission . It is
more likely that the infarct was produced by another mech-
anism, such as thrombosis or embolism (24,25).
Electrocardiographic findings. Prinzmetal's variant
angina is considered the classic clinical manifestation of
coronary artery spasm. ST segmentelevation during angina
was observed in 64% of our patients. Among the remaining
patients, nearly an equal number had either ST segment
depression or no electrocardiographic changeduringangina.
Therefore, the observation of ST elevation during angina
appears to be fairly specific for coronary spasm in patients
without severe coronary obstruction , but it is not very sen-
sitive because patients may manifest a variety of other
electrocardiographic findings during angina. It is possible
that ST elevation during angina would have been observed
more frequently and normal electrocardiograms less fre-
quently during angina if more extensive electrocardio-
graphic monitoring had been performed in our patients.
Robertson et al. (26) concluded that Holter monitor re-
cordings were superior to 12 lead electrocardiograms ob-
tained during pain for detection of ST segment changes in
patients with coronary artery spasm. They found that com-
plete electrocardiograms were often performed just after the
ST segment changes had resolved and while angina was
subsiding. Therefore, we recommend Holter monitor eval-
uation of every patient suspected to have coronary spasm.
BecauseST segment elevation during coronary spasm usu-
ally occurs in inferior electrocardiographic leads, Holter
monitor recordings should include an inferior lead in these
patients (2).
Major arrhythmias during angina occurred in 24% of
our patients. Other authors (10,23,27) have found a simi-
larly high incidence of arrhythmias in patients with pure
coronary spasm.
Medical therapy. A limitation of our analysis of med-
ical therapy is that this study was uncontrolled and retro-
spective. All patients were not treated in exactly the same
manner, and response to treatment was evaluated subjec-
tively. We found that the majority of patients with true
coronary artery spasm did not respond to long-acting ni-
trates. This may have been due in part to inadequate doses,
because it is now morecommon to use higherdosesof long-
acting nitrates than it was 5 to 10 years ago. However. the
average daily dose of isosorbide dinitrate in patients who
were considered unresponsive was 83 mg/day and this is a
commonly used dose even today. We found that among
patients who were unresponsive to nitrate therapy. the ma-
jority responded well to the calcium antagonist agents, ni-
fedipine and verapamil.
Many investigators (28-30) have confirmed that nifedi-
pine, verapamil and diltiazem are highly effective in the
treatment of spasm in the presence of normal or nearly
normal coronary arteries. When coronary spasm is super-
imposed on fixed atherosclerotic obstruction, these calcium
antagonist drugs are at least as effective as long-acting ni-
trates (31.32) .
Waters et al. (33) used provocative testing with ergo-
novine to assess the efficacy of treatment with nifedipine,
diltiazem and verapamil in patients with coronary artery
spasm. In 27 patients (9 patients with pure coronary spasm)
witha positive ergonovine test beforetreatment, oneof these
drugspartially or totallyblockedergonovine-induced angina
and ST segment elevation in most patients. An ergonovine
test that became negative while the patient was receiving
treatment was strongly correlated with a favorable clinical
response to the drug.
Pacemaker therapy. Permanent pacemakerinsertion in
our six patientswas effective in preventing further syncopal
attacks during angina. We believe that permanent pace-
makerinsertion is indicated in most patientswith pure coro-
nary artery spasm who develop complete heart block or
asystole during angina. because control of angina and ar-
rhythmias cannot be guaranteed in these patients even with
calcium antagonist therapy. Nevertheless, pacemaker in-
sertion is not invariably effective in preventing syncope in
patients with coronary spasm and atrioventricular block.
Syncope may also be produced by global ventricular isch-
emia with decreased cardiac output (34). The use of a per-
manent pacemaker for patients with heart block during an-
gina may improve survival.
Prognosis. Patients with pure coronary artery spasm tend
to have a chronic clinical course with varying degrees of
disability due to angina. syncope. arrhythmias and myo-
cardial infarction. Despite the morbidity, no cardiac mor-
tality occurred in our patients during an average clinical
course of nearly 6 years. There have been at least 12 pre-
vious reportsof patients who died becauseof pure coronary
artery spasm (10,15.27.35-42); all died suddenlyduring an
anginal episode. These deaths were probably caused by an
arrhythmia precipitated by acute myocardial ischemia. Eight
of these patients were known to have ventricular tachyar-
rhythmias or complete heart block during angina. In our
experience, antiarrhythmic therapy is not very effective in
controlling ventricular tachyarrhythmias unless attacks of
myocardial ischemia are controlled. Miller et al. (43) ana-
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lyzed multiple clinical factors in patients with coronary spasm
in relation to mortality. They found that only the maximal
degree of ST elevation and the presence of serious arrhyth-
mias correlated with the risk of sudden death .
We thank Patricia Durnwald for her assistance in the preparation of this
manuscript.
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